Forecast Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.4M

  • Investors
  • 8

Forecast General Information

Description

Developer of a preclinical therapeutics platform designed to predict clinical outcomes for central nervous system diseases The company's technology utilizes artificial intelligence and neural circuit readouts to link drug chemistry to patient mental health outcomes, enabling pharmaceutical companies to identify biological correlates of clinical symptoms and improve the predictive power of neurotherapeutic development.

Contact Information

Website
forecast.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 575 Market Street, Floor 7
  • San Francisco, CA 94105
  • United States
+1 (415)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 575 Market Street, Floor 7
  • San Francisco, CA 94105
  • United States
+1 (415)

Forecast Timeline

2026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Forecast Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 27-Aug-2026 $2.4M Completed Pre-Clinical Trials
3. Accelerator/Incubator 16-Mar-2026 Completed Pre-Clinical Trials
2. Accelerator/Incubator 09-Feb-2026 Completed Pre-Clinical Trials
1. Seed Round 01-Jan-2025 Completed Pre-Clinical Trials
To view Forecast’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Forecast Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Breakout Ventures Venture Capital Minority
CQDM Not-For-Profit Venture Capital
Merck Digital Sciences Studio Accelerator/Incubator
MSD Global Health Innovation Fund Corporate Venture Capital
The Venture Collective Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Forecast FAQs

  • When was Forecast founded?

    Forecast was founded in 2025.

  • Where is Forecast headquartered?

    Forecast is headquartered in San Francisco, CA.

  • What industry is Forecast in?

    Forecast’s primary industry is Discovery Tools (Healthcare).

  • Is Forecast a private or public company?

    Forecast is a Private company.

  • What is Forecast’s current revenue?

    The current revenue for Forecast is .

  • How much funding has Forecast raised over time?

    Forecast has raised $2.5M.

  • Who are Forecast’s investors?

    Breakout Ventures, CQDM, Merck Digital Sciences Studio, MSD Global Health Innovation Fund, and The Venture Collective are 5 of 8 investors who have invested in Forecast.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process